SMC subsidiary opens in Switzerland
Advertisement
Special Materials Company (SMC) announces the opening of a European subsidiary in Switzerland, and appoints Christoph Mielke to the post of Global Managing Director of Phosphorous Derivatives.
Mielke’s background includes over 15 years of sales and marketing functions at the CECA/Arkema Group prior to becoming the Managing Director of the new SMC Swiss office.
With this European entity; SMC is committed to expand its business activities in Europe and Asia. The office, based in Canto of Valais, will have a local commercial and logistics team providing an improved level of service and strengthening SMC’s position in these regions.
According to Adam Feldman, SMC’s CEO, “The Swiss office is part of SMC’s strategic objective to expand and strengthen its global presence.”
Other news from the department business & finance
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Celesio
inductar® CS cube | Elemental analyzers | Elementar Analysensysteme
Ditt_Apotek
UL Solutions Acquires Germany-Based Battery Testing and Simulation Company - Deal deepens UL Solutions’ global expertise in battery performance testing and expands global EV battery testing footprint
Vitusapotek
Structure of calcite shells revealed - New research offers clues to how shells grow in nature
Lawtons
Watson's
Alliance_Apotek
Southern_and_Eastern_Norway_Pharmaceutical_Trust
Alliance_Unichem